These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3310851)

  • 1. Abnormal expression of interleukin-3 and leukaemia.
    Hapel AJ; Young IG
    Anticancer Res; 1987; 7(4A):661-7. PubMed ID: 3310851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an autocrine leukaemia using a retroviral expression vector carrying the interleukin-3 gene.
    Hapel AJ; Vande Woude G; Campbell HD; Young IG; Robins T
    Lymphokine Res; 1986; 5(4):249-54. PubMed ID: 3491251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line.
    Matulonis U; Salgia R; Okuda K; Druker B; Griffin JD
    Exp Hematol; 1993 Oct; 21(11):1460-6. PubMed ID: 8405226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for specific receptors for interleukin 3 on lymphokine-dependent cell lines established from long-term bone marrow cultures.
    Palaszynski EW; Ihle JN
    J Immunol; 1984 Apr; 132(4):1872-8. PubMed ID: 6421927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection with a Kirsten-retrovirus can induce a multiplicity of tumorigenic phenotypes in the interleukin-3-dependent FDC-P1 cells.
    Duménil D; Neel H; Lacout C; Dautry F
    Exp Hematol; 1994 Feb; 22(2):178-85. PubMed ID: 8299738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytokine receptor repertoire specifies autocrine growth factor production in factor-dependent cells.
    Rasko JE; Metcalf D; Gough NM; Begley CG
    Exp Hematol; 1995 May; 23(5):453-60. PubMed ID: 7720817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine transformation of hemopoietic cells resulting from cytokine message stabilization after intracisternal A particle transposition.
    Algate PA; McCubrey JA
    Oncogene; 1993 May; 8(5):1221-32. PubMed ID: 8479745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of hexose uptake by haemopoietic cell growth factor occurs in WEHI-3B myelomonocytic leukaemia cells: a possible mechanism for loss of growth control.
    Whetton AD; Bazill GW; Dexter TM
    J Cell Physiol; 1985 Apr; 123(1):73-8. PubMed ID: 3882726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of the murine myeloid cell line FDC-P1 to soluble and membrane-bound forms of steel factor (SLF).
    Caruana G; Ashman LK; Fujita J; Gonda TJ
    Exp Hematol; 1993 Jun; 21(6):761-8. PubMed ID: 7684700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The colony-stimulating factors and myeloid leukaemia.
    Nicola NA; Metcalf D
    Cancer Surv; 1985; 4(4):789-815. PubMed ID: 3916644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special Education.
    Kozutsumi H
    Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
    Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular biology of interleukin-3.
    Morris CF; Young IG; Hapel AJ
    Immunol Ser; 1990; 49():177-214. PubMed ID: 2090251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic properties of interleukin 3. II. Serologic comparison of 20-alpha-SDH-inducing activity, colony-stimulating activity, and WEHI-3 growth factor activity by using an antiserum against IL 3.
    Bowlin TL; Scott AN; Ihle JN
    J Immunol; 1984 Oct; 133(4):2001-6. PubMed ID: 6432905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine expression from bone marrow derived macrophages.
    Temeles DS; McGrath HE; Kittler EL; Shadduck RK; Kister VK; Crittenden RB; Turner BL; Quesenberry PJ
    Exp Hematol; 1993 Feb; 21(2):388-93. PubMed ID: 7678817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of FDC-P1 cells to IL-3 independence by a recombinant murine retrovirus containing v-erb-B.
    Shounan Y; Miller M; Symonds G
    Exp Hematol; 1995 Jun; 23(6):492-9. PubMed ID: 7768304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic effects of prolonged melphalan treatment of murine long-term bone marrow cultures and interleukin 3-dependent hematopoietic progenitor cell lines.
    Greenberger JS; Palaszynski EW; Pierce JH; Sakakeeny MA; Ruscetti SK; Ihle JN; Daugherty C
    J Natl Cancer Inst; 1985 Jan; 74(1):247-62. PubMed ID: 3918212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow adherent cell hemopoietic growth factor production.
    Quesenberry P; Song Z; Alberico T; Gualtieri R; Stewart M; Innes D; McGrath E; Cranston S; Kleeman E
    Prog Clin Biol Res; 1985; 184():247-56. PubMed ID: 3931091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral interleukin 5 gene transfer into interleukin 5-dependent growing cell lines results in autocrine growth and tumorigenicity.
    Blankenstein T; Li WQ; Uberla K; Qin ZH; Tominaga A; Takatsu K; Yamaguchi N; Diamantstein T
    Eur J Immunol; 1990 Dec; 20(12):2699-705. PubMed ID: 2269330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of growth of mouse leukemic cell lines in vitro and in vivo by a monoclonal antibody that recognizes an interleukin 3 receptor-associated protein.
    Tweardy DJ; Morel PA; Herberman RB; Sakurai M
    Cancer Res; 1991 Aug; 51(16):4355-9. PubMed ID: 1868459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.